S C Mohapatra

A community evaluative cross-sectional study was undertaken from patients attending two selected dental clinics of Gurugram to record public awareness regarding Dental implants. The patients agreeing to participate in the interview, through predesigned and pre tested proformas were included. Patients were requested for using a closed ended dichotomized questionnaire by 140 patients during their exit from the clinics from 9 AM to 12 noon period. Since the average patient load in dental clinics were not too crowding; the total coverage of the sample was time consuming. While 63% did not have much information regarding dental implants which can be used to replace missing teeth; only 14% wanted more information regarding implants and 39% were attending the clinic to know about dental implants through dentist. The major difference between Dental Implant and Root Canal Treatment (RCT) was not clear to people. Keywords: Dental implants, Community dental awareness.

There are about 1.2 billion smokers worldwide of which estimated about 4 million died every year. Tobacco consumption is a common habitual concern in India; in two major Forms such as Smoking and Chewing tobaccos. Smoking includes Cigarette, Bidi Hukkah and other forms of consumption while Chewing tobaccos include Khaini, Gutka, Mawa, Dukta, Snuff, Gudakhu and other forms. The cancer reported by Chewing forms of Tobaccos are known as CIT (Chewable Indian Tobacco) Cancers. The CIT cancers more seen in India and adjacent countries like Nepal, Bangladesh, Pakistan, Sri Lanka etc, than western part of the globe. It has been calculated that 26 grams of CIT for 20 years will produce oral cancer in genetically coded people. It is a major problem in Oncology, Oral medicine as well as Public Health. Although tobacco smoking has reduced in the recent past in India, tobacco consumption / smoking is leading preventable cause of death due to cancer in males. Cigarette smoking also complicates morbidities related pulmonary conditions like Asthma, COPD, Cancer and COVID etc. A dynamic comprehensive approach is required for breaking the habit of tobacco consumption in any form. Various studies conducted in the past proposed that intensive tobacco cessation interventions involving behavioural support plays an important role in the treatment of addiction / deaddiction. Public health professionals can play an important role in creating awareness among people regarding the ill effects of tobacco through different community communication technologies. It is important that government has passed trading restrictions in order to curb the tobacco consumption through primordial prevention method. Advertisement and promotion of tobacco products are also banned throughout the country, though it continues in one form or other. Many NGO as well as Government sectors have taken initiatives at central and state level to establish tobacco cessation clinics (TCCs) in fewer instances. Behaviour Change in Tobaccoreplacement therapy, Smoking. Keywords: Behaviour Change in Tobacco, Nicotine replacement therapy, Smoking.

Background: COPD exacerbations were diagnosed based on the clinical parameters only. Till now we were unable to find out a reliable blood based biomarker. Serum IgE is one of the measurements of airway inflammation which is well established in asthma, it’s role in COPD not studied adequately. Materials and Methods: This is a cross sectional study conducted in a tertiary care center. This study included 75 COPD patients who were admitted in our hospital for exacerbations. Exacerbations defined by the GOLD report 2018. Complete history & Total serum IgE levels were obtained from all patients during admission, pulmonary function test has been done at the time of discharge and results were analyzed. Results: In our study the mean value of serum IgE is 416.75 IU/L. Patients who had elevated serum IgE (>100 IU/L) levels were 55 (73.3%). FEV1/FVC ratio significantly high in elevated IgE group (0.580.09 in elevated IgE vs 0.490.10 in IgE not elevated, p more in elevated IgE group (13.7%+185ml in elevated IgE vs 6.4%+73ml in IgE not elevated, p=0.001). IgE elevated patients have seasonal variation history, Biomass exposure history. They had more Asthma COPD Overlap features than IgE not elevated group (p=0.001). Conclusion: COPD patients can have elevated serum IgE levels during exacerbations. IgE may play an important role in pathogenesis of COPD and can be used as a biomarker for COPD Exacerbations. Key message: Serum total IgE can be used as a biomarker in COPD exacerbations. This can be used as a new therapeutic target for the same. Keywords: Humans, Chronic obstructive pulmonary, Disease, Biomarkers, Immunoglobulin E, Asthma.